# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported b...
Wedbush analyst Tom Nikic maintains Allbirds (NASDAQ:BIRD) with a Neutral and lowers the price target from $1 to $0.9.